Literature DB >> 18977004

Late onset Huntington Disease: clinical and genetic characteristics of 34 cases.

Hillary Lipe1, Thomas Bird.   

Abstract

We performed a retrospective observational study of thirty-four persons with late onset of Huntington Disease (HD) (onset range 60-79 years). CAG trinucleotide expansion size ranged from 38-44 repeats. Even at this late age a significant negative correlation (r=-0.421, p<0.05) was found between the length of repeat and age of onset. Important characteristics of these older subjects were: (1)Most (68%) were the first in the family to have a diagnosis of HD, (2) Motor problems were the initial symptoms at onset, (3) Disability increased and varied from mild to severe (4) Disease duration was somewhat shorter (12 years) than that reported for mid-life onset, (5) Death was often related to diseases of old age, such as cancer and cerebrovascular disease, (6) Serious falls were a major risk and (7) Global dementia may be associated with coincident Alzheimer disease. Recognizing these characteristics will help physicians and other health care providers better identify and follow the late onset presentation of this disease.

Entities:  

Mesh:

Year:  2008        PMID: 18977004      PMCID: PMC3140172          DOI: 10.1016/j.jns.2008.09.029

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  16 in total

1.  Differences in duration of Huntington's disease based on age at onset.

Authors:  T Foroud; J Gray; J Ivashina; P M Conneally
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-01       Impact factor: 10.154

2.  Late-onset Huntington's disease: a clinical and molecular study.

Authors:  C M James; G D Houlihan; R G Snell; J P Cheadle; P S Harper
Journal:  Age Ageing       Date:  1994-11       Impact factor: 10.668

3.  The likelihood of being affected with Huntington disease by a particular age, for a specific CAG size.

Authors:  R R Brinkman; M M Mezei; J Theilmann; E Almqvist; M R Hayden
Journal:  Am J Hum Genet       Date:  1997-05       Impact factor: 11.025

4.  The association of CAG repeat length with clinical progression in Huntington disease.

Authors:  A Rosenblatt; K-Y Liang; H Zhou; M H Abbott; L M Gourley; R L Margolis; J Brandt; C A Ross
Journal:  Neurology       Date:  2006-04-11       Impact factor: 9.910

5.  Falls and gait disturbances in Huntington's disease.

Authors:  Yvette A M Grimbergen; Mirjam J Knol; Bastiaan R Bloem; Berry P H Kremer; Raymund A C Roos; Marten Munneke
Journal:  Mov Disord       Date:  2008-05-15       Impact factor: 10.338

6.  A longitudinal study of drivers with Alzheimer disease.

Authors:  B R Ott; W C Heindel; G D Papandonatos; E K Festa; J D Davis; L A Daiello; J C Morris
Journal:  Neurology       Date:  2008-01-23       Impact factor: 9.910

7.  Geriatric neurogenetics: oxymoron or reality?

Authors:  Thomas D Bird; Hillary P Lipe; Ellen J Steinbart
Journal:  Arch Neurol       Date:  2008-04

8.  Huntington's disease as caused by 34 CAG repeats.

Authors:  Jürgen Andrich; Larissa Arning; Stefan Wieczorek; Peter H Kraus; Ralf Gold; Carsten Saft
Journal:  Mov Disord       Date:  2008-04-30       Impact factor: 10.338

Review 9.  Driving and neurodegenerative diseases.

Authors:  Ergun Y Uc; Matthew Rizzo
Journal:  Curr Neurol Neurosci Rep       Date:  2008-09       Impact factor: 5.081

10.  Molecular analysis of late onset Huntington's disease.

Authors:  B Kremer; F Squitieri; H Telenius; S E Andrew; J Theilmann; N Spence; Y P Goldberg; M R Hayden
Journal:  J Med Genet       Date:  1993-12       Impact factor: 6.318

View more
  15 in total

1.  [Choreatic syndrome at 79 years old: late manifestation of Huntington's chorea].

Authors:  I Vachalova; V Golden; J Großkopf; J G Heckmann
Journal:  Nervenarzt       Date:  2013-12       Impact factor: 1.214

2.  Is late-onset schizophrenia a subtype of schizophrenia?

Authors:  I V Vahia; B W Palmer; C Depp; I Fellows; S Golshan; H C Kraemer; Dilip V Jeste
Journal:  Acta Psychiatr Scand       Date:  2010-11       Impact factor: 6.392

3.  Comparison of mid-age-onset and late-onset Huntington's disease in Finnish patients.

Authors:  Jussi O T Sipilä; Tommi Kauko; Markku Päivärinta; Kari Majamaa
Journal:  J Neurol       Date:  2017-08-28       Impact factor: 4.849

Review 4.  Neurotheranostics as personalized medicines.

Authors:  Bhavesh D Kevadiya; Brendan M Ottemann; Midhun Ben Thomas; Insiya Mukadam; Saumya Nigam; JoEllyn McMillan; Santhi Gorantla; Tatiana K Bronich; Benson Edagwa; Howard E Gendelman
Journal:  Adv Drug Deliv Rev       Date:  2018-10-26       Impact factor: 15.470

5.  Complete suppression of Htt fibrilization and disaggregation of Htt fibrils by a trimeric chaperone complex.

Authors:  Annika Scior; Alexander Buntru; Kristin Arnsburg; Anne Ast; Manuel Iburg; Katrin Juenemann; Maria Lucia Pigazzini; Barbara Mlody; Dmytro Puchkov; Josef Priller; Erich E Wanker; Alessandro Prigione; Janine Kirstein
Journal:  EMBO J       Date:  2017-12-06       Impact factor: 11.598

6.  Huntington disease reduced penetrance alleles occur at high frequency in the general population.

Authors:  Chris Kay; Jennifer A Collins; Zosia Miedzybrodzka; Steven J Madore; Erynn S Gordon; Norman Gerry; Mark Davidson; Ramy A Slama; Michael R Hayden
Journal:  Neurology       Date:  2016-06-22       Impact factor: 9.910

7.  An International Survey-based Algorithm for the Pharmacologic Treatment of Chorea in Huntington's Disease.

Authors:  Jean-Marc Burgunder; Mark Guttman; Susan Perlman; Nathan Goodman; Daniel P van Kammen; Lavonne Goodman
Journal:  PLoS Curr       Date:  2011-08-30

8.  Oromandibular dyskinesia as the initial manifestation of late-onset huntington disease.

Authors:  Dong-Seok Oh; Eun-Seon Park; Seong-Min Choi; Byeong-Chae Kim; Myeong-Kyu Kim; Ki-Hyun Cho
Journal:  J Mov Disord       Date:  2011-10-30

Review 9.  Dysphagia as a risk factor for mortality in Niemann-Pick disease type C: systematic literature review and evidence from studies with miglustat.

Authors:  Mark Walterfang; Yin-Hsiu Chien; Jackie Imrie; Derren Rushton; Danielle Schubiger; Marc C Patterson
Journal:  Orphanet J Rare Dis       Date:  2012-10-06       Impact factor: 4.123

Review 10.  Gene targeting techniques for Huntington's disease.

Authors:  Eric Fields; Erik Vaughan; Deepika Tripu; Isabelle Lim; Katherine Shrout; Jessica Conway; Nicole Salib; Yubin Lee; Akash Dhamsania; Michael Jacobsen; Ashley Woo; Huijing Xue; Kan Cao
Journal:  Ageing Res Rev       Date:  2021-06-05       Impact factor: 11.788

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.